Ensysce Biosciences, Inc. (ENSC) vs Enveric Biosciences, Inc. (ENVB)
A side-by-side comparison of Ensysce Biosciences, Inc. and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENSC
Ensysce Biosciences, Inc.
$0.42HealthcareDelayed quote: Oct 6, 2026, 12:23 PM EDT
ENVB
Enveric Biosciences, Inc.
$1.48HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — ENSC vs ENVB
growth of $100 · dividends reinvested · last 8yENSC -100.0% (-76.2%/yr)ENVB -100.0% (-79.7%/yr)ENSC compounded faster over this window
ENSC ENVB
ENSC vs ENVB: by the numbers
- •ENVB is the larger company ($7M vs $6M market cap).
- •Both run net losses; ENVB's is the smaller (0.00% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | ENSC | ENVB |
|---|---|---|
| P/S ratio | 5.54 | N/A |
| P/B ratio | N/A | 0.82 |
Profitability
| Metric | ENSC | ENVB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -1084.23% | 0.00% |
| ROE | N/A | -108.00% |
| ROIC | N/A | -107.99% |
Growth (annualized)
| Metric | ENSC | ENVB |
|---|---|---|
| Total return CAGR (5Y) | -86.22% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.